Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
Key Information
Due Date: January 7, 2025
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Grant, Government
Match Required: No
Status: Posted
Contact Info:
OERWebmaster03@od.nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
The Exploratory/Developmental Bioengineering Research Grants (EBRG), which may include clinical trials, is a funding opportunity that focuses on the engineering aspects of bioengineering research. The main aim of these grants is to encourage researchers to submit EBRG applications. These applications should focus on proving the feasibility and potential usefulness of new resources or advancements in bioengineering research. These improvements could range from the quality, speed, efficiency, functionality, cost-effectiveness, or accessibility of solutions. The problems these solutions aim to solve should be related to basic biomedical research, pre-clinical studies, clinical research, delivery of clinical care, or improving accessibility to these services.
Show More
Key Dates
Open Date: January 11, 2022
Application Due Date: January 7, 2025
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses